Advertisement
Bausch & Lomb
Subscribe to Bausch & Lomb

The Lead

Valeant Pharmaceuticals Expands Bausch + Lomb Manufacturing Facility, Adding 120 New Jobs in Rochester, NY

September 9, 2014 8:39 am | News | Comments

Valeant Pharmaceuticals hosted a ribbon cutting ceremony for the new Bausch + Lomb ULTRA contact lens manufacturing lines and solar array assembly at the company's Optics Center in Rochester, NY. The ceremony recognized the expansion and installation of the new manufacturing lines, which will produce the company's silicone hydrogel contact lens, Bausch + Lomb ULTRA.

China Fines Eye-Care Companies on Pricing Charges

May 30, 2014 12:33 am | by The Associated Press | News | Comments

China has fined Johnson & Johnson, Nikon and five other foreign makers of eyeglasses and...

Valeant Posts First Quarter Net Loss but Revenues Jump 77%

May 8, 2014 8:10 am | by The Canadian Press | News | Comments

Valeant says the loss includes restructuring, integration and other charges of $135 million...

Bausch and Lomb Acquisition Proving Profitable for Valeant

February 27, 2014 3:51 pm | by Ross Marowits, The Canadian Press | News | Comments

Valeant Pharmaceuticals is seeing more clearly the merits of its acquisition last summer of eye...

View Sample

FREE Email Newsletter

Bausch & Lomb to Expand New York Production

November 26, 2013 10:44 am | News | Comments

New York officials say a $5.8 million grant and up to $6.2 million in tax credits have figured into Bausch & Lomb's decision to expand manufacturing and distribution in Rochester, N.Y. Gov. Andrew Cuomo says Valeant Pharmaceutical International will invest $106 million to expand capacity for its subsidiary's new line of contact lenses.

Forest Laboratories Names New CEO and President

September 10, 2013 8:18 am | News | Comments

Forest Laboratories, Inc. today announced that Brenton L. Saunders, 43, the former Chief Executive Officer of Bausch + Lomb, has been appointed Forest'€™s Chief Executive Officer and President, effective October 1, 2013. Mr. Saunders, who will succeed Howard Solomon, has served as a Forest director since August 2011.

Valeant to Cut Jobs, Move Bausch and Lomb HQ

July 29, 2013 3:58 pm | News | Comments

Valeant said Monday that it will eliminate as much as 15 percent of its workforce and move Bausch & Lomb's headquarters to New Jersey as part of its $8.7 billion acquisition of the company.In a letter to its own and Bausch & Lomb workers, Valeant said that after the deal closes, it will eliminate between 10 percent and 15 percent of positions companywide. That works out to between 1,850 and 2,775 people.

Advertisement

Valeant to Buy Bausch + Lomb for $8.7B

May 27, 2013 9:38 am | by LINDA A. JOHNSON,AP Business Writer | News | Comments

Canadian drugmaker Valeant Pharmaceuticals says it will buy eye-health company Bausch + Lomb for $8.7 billion in cash in a massive expansion of its ophthalmology business. Valeant says the deal will help it capitalize on increasing demand for contact lenses and other products because of aging...

Bausch + Lomb and Lions Clubs International

September 28, 2012 9:21 am | by Bausch + Lomb | News | Comments

Bausch + Lomb and Lions Clubs International Foundation (LCIF) awarded the Tianjin Eye Hospital a grant to finance a specialized pediatric cataract training initiative. The grant is made possible through the Pediatric Cataract Initiative (PCI).

Bausch + Lomb Completes the Acquisition of ISTA Pharmaceuticals

June 7, 2012 4:09 am | News | Comments

Bausch + Lomb announced today that it has completed its acquisition of ISTA Pharmaceuticals, Inc.  The addition of ISTA bolsters Bausch + Lomb's product portfolio and pipeline, increasing the company's therapeutic offerings for physicians and their patients and creating opportunity for future growth.

Bausch + Lomb to Launch Pharmaceuticals Business in India

June 30, 2011 4:34 am | News | Comments

Bausch + Lomb has announced plans to launch a pharmaceutical business in India through a strategic agreement with Micro Labs, a leading provider of quality healthcare products.

Bausch + Lomb Appoints David Mordaunt, Ph.D. as Vice President, Development and Research, Surgical

March 24, 2011 1:22 pm | by Bausch + Lomb | News | Comments

Bausch + Lomb is one of the best-known and most respected healthcare companies in the world. Its core businesses include contact lenses and lens care products, ophthalmic surgical devices and instruments, and ophthalmic pharmaceuticals. Founded in 1853, the company is headquartered in Rocheste

Advertisement

Hi-Tech Pharmacal Acquires Nystatin Oral Suspension ANDA

March 21, 2011 5:08 am | News | Comments

Hi-Tech Pharmacal has acquired the rights to the Abbreviated New Drug Application (ANDA) for Nystatin Oral suspension from Bausch + Lomb, the global eye health company for an undisclosed upfront payment and a future royalty.

Bausch + Lomb Appoints Dr. Calvin W. Roberts as Chief Medical Officer(2)

March 18, 2011 5:06 am | News | Comments

Bausch + Lomb has announced the appointment of Calvin W. Roberts, M.D. to the newly created position of Chief Medical Officer (CMO). Dr. Roberts will serve as a member of the Executive Leadership Team and coordinate the company's global D&R efforts across the Vision Care, Pharmaceuticals and Surgical business units for greater leverage and outcomes.

Bausch + Lomb Appoints Dr. Calvin W. Roberts as Chief Medical Officer

March 18, 2011 4:21 am | by Bausch + Lomb | News | Comments

Bausch + Lomb, the global eye health company, today announced the appointment of Calvin W. Roberts, M.D., to the newly created position of Chief Medical Officer (CMO).

Bausch + Lomb Activates Relief Aid to Earthquake and Tsunami Disaster in Japan

March 11, 2011 8:21 am | by Bausch + Lomb | News | Comments

Bausch + Lomb, the global eye health company, announced today that it is activating a relief support plan in response to the earthquake and tsunami disaster affecting Japan.

Bausch + Lomb Storz® Ophthalmics Introduces the Osher Sterile Field Magnifier

March 9, 2011 8:21 am | by Bausch + Lomb | News | Comments

Stephanie Haenchen Sr. Marketing Coordinator, Surgical Instruments +1-636-226-3788 or stephanie.haenchen@bausch.com

Advertisement

Bausch + Lomb Introduces the Putterman Consecutive CDCR Set

February 24, 2011 7:22 am | by Bausch + Lomb | News | Comments

Bausch + Lomb Instruments for Ophthalmology, Ear, Nose, Throat and Plastic Surgery announced the launch of the Putterman Consecutive Conjunctivodacryocystorhinostomy Set in the United States.

Partnership Announces Inaugural Research Grants to Fight Childhood Blindness

February 3, 2011 5:23 am | by Bausch + Lomb | News | Comments

The Pediatric Cataract Initiative has announced its inaugural small research grant recipients for treating and preventing vision loss in children.

Keep Your Kids’ Eyes Safe During Spring Sports Season

January 31, 2011 9:21 am | by Bausch + Lomb | News | Comments

Dr. Scott Lambert, a professor of ophthalmology at Emory University and a member of the advisory council for the Pediatric Cataract Initiative, offers parents tips to help protect kids’ eyes during spring activities.

Bausch + Lomb Announces Global Licensing Agreement with UltraVision CLPL to Market KeraSoft® Contact Lenses

January 31, 2011 4:21 am | by Bausch + Lomb | News | Comments

Bausch + Lomb announced today a global licensing agreement with U.K.-based UltraVision CLPL to market and sell KeraSoft® soft contact lenses throughout the world, through the network of Bausch + Lomb lab channel partners.

Bausch + Lomb Manufacturing Sites in Florida Achieve Globally Recognized Certifications for Environment, Health, and Safety Management

January 26, 2011 8:22 am | by Bausch + Lomb | News | Comments

Bausch + Lomb announced today that it has secured two globally recognized certifications at its Tampa, Fla., and Clearwater, Fla., manufacturing sites.

Global Study Reveals Patients’ Vision Care Priorities

January 25, 2011 5:23 am | by Bausch + Lomb | News | Comments

In a recent global study to determine the hierarchy of vision-corrected patient needs, seeing better was the most important consideration for selecting eye care products.

Bausch + Lomb Storz® Ophthalmics Introduces Additions to its Single-Use Vitreoretinal Instruments Line

January 24, 2011 7:20 am | by Bausch + Lomb | News | Comments

Bausch + Lomb Storz® Ophthalmic Instruments is launching several new products to expand its line of single-use vitreoretinal instrumentation in the United States.

Bausch + Lomb Offers Crystalens® iClear iPhone Application

January 10, 2011 7:22 am | by Bausch + Lomb | News | Comments

Bausch + Lomb, the global eye health company, announced today that it is offering a free iPhone application, called Crystalens® iClear, that will educate and entertain consumers about vision, cataracts and the B+L Crystalens product.

Voluntary Recall of Soothe® Xtra Hydration (XH) Eye Drops

January 5, 2011 5:22 am | by Bausch + Lomb | News | Comments

Voluntary Recall of Soothe® Xtra Hydration (XH) Eye Drops

Bausch + Lomb Appoints Rick Heinick as Corporate Vice President, Global Human Resources and Transformation

December 21, 2010 8:21 am | by Bausch + Lomb | News | Comments

Bausch + Lomb, the global eye health company, has named Rick Heinick as corporate vice president, Global Human Resources and Transformation, effective January 4, 2011.

Bausch + Lomb Extends Crystalens® Patient Rebate Program

December 20, 2010 9:20 am | by Bausch + Lomb | News | Comments

Bausch + Lomb, the global eye health company, announced today that it will extend its "See Better and Save" patient rebate program for patients who have the Crystalens® accommodating intraocular lens (IOL) implanted before March 31, 2011.

Bausch + Lomb Storz® Ophthalmics Introduces a New Line of Single-Use Cataract Instruments

December 8, 2010 5:21 am | by Bausch + Lomb | News | Comments

Bausch + Lomb Storz® Ophthalmic Instruments has launched a new line of single-use cataract instrumentation in the United States.

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading